Skip to main content

Table 1 The characterization of tocol NLCs by particulate size, polydispersity index (PDI), zeta potential, and CLA encapsulation percentage

From: Facile adipocyte uptake and liver/adipose tissue delivery of conjugated linoleic acid-loaded tocol nanocarriers for a synergistic anti-adipogenesis effect

Formulation

Size (nm)

PDI

Zeta potential (mV)

CLA encapsulation (%)

Tocol NLCs (S)

120.53 ± 0.75

0.25 ± 0.02

-46.13 ± 2.62

96.32 ± 2.08

Tocol NLCs (M)

137.37 ± 0.48

0.24 ± 0.01

-43.77 ± 0.55

98.23 ± 3.40

Tocol NLCs (L)

151.43 ± 1.14

0.23 ± 0.01

-39.63 ± 0.32

99.59 ± 5.68

  1. PDI, polydispersity index
  2. Each value represents the mean ± SEM (n = 3)